• Home
  • About Us
    • About ReNeuron
    • Board of Directors
    • Senior Management
    • Advisory Board
    • Working at ReNeuron
    • Patents
  • Exosomes
  • iPSC
  • Partnering
    • Existing Partnerships & Collaborations
  • News
  • Investors
    • Investor Centre
    • Corporate Governance
    • Share Price Information
    • Major Shareholdings
    • Advisors
    • Analyst Research
    • Webcasts and Presentations
    • Financial Reports
    • General Meetings
    • Financial Calendar
    • Email alerts
    • RNS Notifications
    • Documents and Circulars
    • AIM Rule 26
    • Declarations
  • Contact
    • Contact Us
ReNeuron logo
ReNeuron logo
  • Home
  • About Us
    • About ReNeuron
    • Board of Directors
    • Senior Management
    • Advisory Board
    • Working at ReNeuron
    • Patents
  • Exosomes
  • iPSC
  • Partnering
    • Existing Partnerships & Collaborations
  • News
  • Investors
    • Investor Centre
    • Corporate Governance
    • Share Price Information
    • Major Shareholdings
    • Advisors
    • Analyst Research
    • Webcasts and Presentations
    • Financial Reports
    • General Meetings
    • Financial Calendar
    • Email alerts
    • RNS Notifications
    • Documents and Circulars
    • AIM Rule 26
    • Declarations
  • Contact
    • Contact Us

The Stem Cell-based Exosome Company 

ReNeuron is developing the next generation of engineered Exosomes.  Utilising our stem cell-based technologies, targeting tissues of interest and delivering payloads of choice.

Click here to access the presentation at Cell 2023 on 8 November

About ReNeuron

Partnering

Patents Read more

Latest News

View all

Interim Results for the six months ended 30 September 2023

ReNeuron presents in vivo data at Cell 2023

R&D Update

Result of AGM

Notice of Annual General Meeting

Share Price

More details

3.47p 0.020p

at 05-02-2024 1:22:01

15 minute delayed share price from London Stock Exchange provided by Euroland.

Share Price

More details

3.47p 0.020p

at 05-02-2024 1:22:01

15 minute delayed share price from London Stock Exchange provided by Euroland.

Exosomes

Read more

iPSC

CTX cells for Critical Limb Ischaemia Read more

Investor Centre

Investor Centre banner image Read more

Subscribe here for our Press Releases:

The information collected will be used to send you the information you have requested and to provide information that may be useful to you. ReNeuron may share non-personal aggregate statistics (group) data about ReNeuron’s website visitors with partners or other parties. However, ReNeuron will not sell or share any information about individual users. Please ensure you have read the full contents of our Privacy Notice before continuing. If you agree to your information being used in this way, please tick the box: 

© ReNeuron Group plc 2024 All rights reserved

Website design by Carr Kamasa Design

  • Privacy Notice
  • Disclaimer